Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 30 ... Apoptosis (XIAP) Antisense AEG35156 Given in Combination with High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction ...
2009 AUG 24 ... that it has received approval from the U.S. Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). ...
2009 NOV 1 ... (PETHEMA LPA96 and LPA99) received induction therapy-with all-trans retinoic acid and idarubicin," scientists writing in the Haematologica - the Hematology Journal report. ...
2009 OCT 5 ... sibling partially T-cell-depleted HSCT (0.5 x 10(6) CD3(+) T cells per kg) following idarubicin-containing conditioning regimens. NOD2 polymorphisms were present in 14 of 85 (16.5%) of ...
2009 JUN 22 ... for relapsed ALL. To improve the induction remission rate, we modified the dose of idarubicin in the original Children's Cancer Group (CCG)-1884 protocol, and retrospectively ...
2009 JUL 27 ... we account for the long-term clinical outcome of enrolled patients. Patients received idarubicin and cytarabine in standard doses as induction therapy and consolidation courses included ...
2009 MAR 30 ... therapy consisted of standard treatment with all-trans-retinoic-acid (AT RA) and idarubicin. Subsequent cytological and molecular analysis of bone marrow demonstrated complete ...
2009 JUN 1 ... in AML-2/ARC cells, but not in Ara-C sensitive AML-2/IDA cells that were resistant to idarubicin. The decreased expression of dCK also resulted in lower activity in both Ara-C resistant ...
2009 OCT 12 ... acute myeloid leukemia (AML) secured, he began induction chemotherapy with idarubicin and cytarabine. Two weeks later, he died of fungal septicemia and multiorgan failure. ...
2009 NOV 30 ... collected in Shanghai (1984 1994). Induction chemotherapeutic regimens based on idarubicin, daunorubicin or homoharringtonine all had similar CR rates and survivals. Karyotype was ...
2009 AUG 10 ... National University. The researchers concluded: "FLAG chemotherapy without idarubicin is a relatively effective and well-tolerated regimen for relapsed or refractory AML and ...
2009 MAY 11 ... plus mitoxantrone and 3 achieved complete remission. Two patients treated with idarubicin plus cytarabine. Both of them achieved complete remission. One case was given cytarabine ...
2009 NOV 23 ... myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin,' are discussed in a new report. According to recent research from the United States, ...
2009 NOV 23 ... blood and on bone marrow aspiration smears. Chemotherapy with cytosine arabinoside and idarubicin was ineffective and the patient died of multi-organ failure with rapidly progressing ...
2009 OCT 19 ... cyclophosphamide, vincristine, adriamycin, dexamethasone) plus imatinib/dasatinib or idarubicin plus cytarabine (Ara-C); 2 did not respond, 1 had CCyR, and 1 short-lasting complete ...
2009 NOV 2 ... Glutaraldehyde is often used as crosslinking agent to link the drugs, including idarubicin (IDA) to the cells." "The previous studies indicated that in ...
2009 OCT 5 ... One hundred seventy-nine patients received induction chemotherapy with cytarabine and idarubicin (AId) regimen. One hundred nineteen patients achieved complete remission (CR) after ...
2009 NOV 9 ... patients were treated with the highest planned dose of 350 mg/m(2) in combination with idarubicin and high-dose cytarabine reinduction chemotherapy. Correlative studies were conducted to ...
